Precigen Inc

NASDAQ: PGEN
$1.04
+$0.04 (+4.3%)
Closing Price on September 18, 2024

PGEN Chart and Intraday Price

PGEN Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TRADE & SERVICES
Industry SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Address 1750 KRAFT DRIVE, SUITE 1400, BLACKSBURG, VA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 420.67M USD
Shares Outstanding 248,919,000
Precigen, Inc., originally known as Intrexon Corporation, is a biopharmaceutical company based in Germantown, Maryland, focusing on developing gene and cell therapies. With a foundation laid in 1998, Precigen advances treatments for a variety of diseases, including those in immuno-oncology, autoimmune disorders, and infectious diseases. The company's innovative precision technology propels its pipeline of preclinical and clinical therapies towards commercialization, aiming to revolutionize biotherapeutic solutions.

PGEN Articles

3 Penny Stocks to Buy With $500
Are you interested in investing in penny stocks? Though doing so does come with risk, making the right investment decisions in the penny stock category can produce eye-opening returns. While the...
Joshua Rodriguez
Published:

10% Owner Funds Trucking Acquisition, Plus More Big Insider Buying
A beneficial owner made a huge buy of shares in a trucking company this past week. That was not the only big insider buying though.
Trey Thoelcke
Published: